LONDON BROKER RATINGS: Experian on JPMorgan focus list at 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations on Thursday morning and on Wednesday: Read More
| Price | 3,351.00p on 12-12-2025 at 15:18:51 |
|---|---|
| Change | 39.00p 1.18% |
| Buy | 3,351.00p |
| Sell | 3,350.00p |
| Last Trade: | Unknown 88.00 at 3,350.50p |
| Day's Volume: | 407,991 |
| Last Close: | 3,312.00p |
| Open: | 3,330.00p |
| ISIN: | GB00B19NLV48 |
| Day's Range | 3,326.00p - 3,380.00p |
| 52wk Range: | 3,049.00p - 4,101.00p |
| Market Capitalisation: | £30.63b |
| VWAP: | 3,359.00226p |
| Shares in Issue: | 914.03m |
Experian (EXPN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 88 | 3,350.50p | OTC Trade |
15:18:50 - 12-Dec-25 |
| Buy* | 88 | 3,350.50p | SI Trade |
15:18:50 - 12-Dec-25 |
| Buy* | 93 | 3,350.50p | SI Trade |
15:18:46 - 12-Dec-25 |
| Unknown* | 93 | 3,350.50p | OTC Trade |
15:18:46 - 12-Dec-25 |
| Sell* | 22 | 3,351.00p | Automatic Execution |
15:18:42 - 12-Dec-25 |
| Buy* | 93 | 3,352.00p | SI Trade |
15:18:23 - 12-Dec-25 |
| Unknown* | 93 | 3,352.00p | OTC Trade |
15:18:23 - 12-Dec-25 |
| Sell* | 1,000 | 3,351.583p | Ordinary |
15:17:27 - 12-Dec-25 |
| Sell* | 162 | 3,353.00p | Automatic Execution |
15:17:12 - 12-Dec-25 |
| Sell* | 22 | 3,354.00p | Automatic Execution |
15:17:06 - 12-Dec-25 |
Experian (EXPN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Dec 2025 7:00 am | RNS | Transaction in Own Shares |
| 28th Nov 2025 12:35 pm | RNS | Total Voting Rights |
| 28th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 27th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 26th Nov 2025 5:15 pm | RNS | Holding(s) in Company |
| 26th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 25th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 24th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 14th Nov 2025 9:30 am | RNS | Director/PDMR Shareholding |
| 13th Nov 2025 9:30 am | RNS | Director/PDMR Shareholding |